| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥87.2B | ¥82.5B | +5.7% |
| Operating Income | ¥4.7B | ¥4.0B | +17.1% |
| Ordinary Income | ¥4.2B | ¥3.3B | +27.1% |
| Net Income | ¥0.1B | ¥-0.9B | +106.7% |
| ROE | 0.2% | -2.5% | - |
FY2025 consolidated results: Revenue 87.2B yen (+5.7% YoY), Operating Income 4.7B yen (+17.1% YoY), Ordinary Income 4.2B yen (+27.1% YoY), Net Income 0.1B yen (turnaround from -0.9B yen loss in prior year, +106.7% YoY). The company achieved revenue growth driven by injection molding precision mold segment expansion, with operating leverage improving profitability. Operating margin expanded to 5.4% from 4.9% YoY, reflecting effective SG&A cost control. However, Net Income was significantly impacted by extraordinary losses of 0.5B yen (primarily impairment loss of 0.3B yen) and interest expenses of 0.5B yen, resulting in modest Net Income of 0.1B yen despite strong operating performance. Basic EPS improved to 28.50 yen from 17.19 yen (+65.8% YoY), reflecting the earnings recovery. The company demonstrates solid cash generation with Operating CF of 9.3B yen (+8.4% YoY) and positive Free CF of 3.0B yen after capital expenditures.
Revenue increased 4.7B yen (+5.7%) to 87.2B yen, driven primarily by the Injection Molding Precision Mold and Molding System segment, which grew 20.0% YoY to 30.9B yen (external sales basis). The Precision Molded Products segment remained relatively flat at 56.3B yen (-0.8% YoY). Geographically, Japan (+7.6% to 23.1B yen), China (+18.8% to 23.0B yen), and Thailand (+9.2% to 15.5B yen) contributed to growth, while Indonesia declined (-6.7% to 17.9B yen). The largest customer, PT Astemo Indonesia Automotive System, contributed 9.4B yen in sales (10.8% of total revenue), down from 10.4B yen prior year. Gross profit increased 1.6B yen (+9.6%) to 18.0B yen with gross margin improving to 20.7% from 19.9% YoY, reflecting favorable product mix from higher-margin mold sales and operational efficiency gains. SG&A expenses increased 0.5B yen (+3.9%) to 13.3B yen, growing slower than revenue, resulting in SG&A ratio improvement to 15.2% from 15.5% YoY.
Operating Income expanded 0.7B yen (+17.1%) to 4.7B yen with operating margin improving 0.5pt to 5.4%. The improvement was driven by operating leverage as revenue growth outpaced cost increases. Non-operating expenses increased 0.2B yen to net expense of 0.5B yen, primarily due to interest expense of 0.5B yen (flat YoY) and foreign exchange losses of 0.1B yen. Ordinary Income grew 0.9B yen (+27.1%) to 4.2B yen. Extraordinary losses totaled 0.5B yen, comprising impairment loss of 0.3B yen (versus 0.01B yen prior year) and other disposal losses. These non-recurring items represented 22.3% of pre-tax income, significantly impacting earnings quality. After tax expense of 1.4B yen (effective tax rate 37.8%), Net Income attributable to owners reached 0.1B yen, representing a turnaround from -0.9B yen loss prior year. The substantial gap between Operating Income (4.7B yen) and Net Income (0.1B yen) reflects the combined impact of interest expenses (0.5B yen), extraordinary losses (0.5B yen), and tax burden (1.4B yen), which collectively consumed 97.9% of operating profit. This represents a revenue up/profit up pattern, with operating leverage driving strong operating profit growth, though bottom-line results were constrained by non-operating and extraordinary items.
The Injection Molding Precision Mold and Molding System segment generated revenue of 31.8B yen (including intersegment sales of 0.9B yen) with Operating Income of 1.7B yen, achieving an operating margin of 5.2%. This segment grew 18.5% YoY in revenue and more than doubled its operating profit from 0.8B yen prior year (+107.6%), driven by increased demand for precision molds from automotive and industrial customers. The Precision Molded Products and Other segment, representing the core business with larger scale, generated revenue of 56.3B yen (external sales only) with Operating Income of 3.2B yen and operating margin of 5.7%. While revenue declined slightly (-0.8% YoY), operating profit decreased 7.5% from 3.4B yen prior year, reflecting pricing pressure and product mix challenges. The margin differential between segments (5.7% for Molded Products versus 5.2% for Molds) is relatively narrow, indicating comparable profitability structures. However, the Mold segment demonstrates stronger momentum with margin expansion potential, while the larger Molded Products segment faces margin pressure warranting attention. Intersegment eliminations totaled 0.9B yen in revenue and 0.1B yen in profit adjustments.
[Profitability] Operating margin 5.4% (improved from 4.9% YoY, +0.5pt), gross margin 20.7% (improved from 19.9% YoY, +0.8pt), net profit margin 0.1% (improved from -1.1% YoY), ROE 0.2% (significantly below historical levels due to extraordinary items impacting net income, compared to negative ROE in prior year). [Cash Quality] Cash and equivalents 18.7B yen (+4.1B yen YoY, +28.3%), representing strong liquidity, short-term debt coverage 1.15x indicating adequate ability to service short-term obligations of 16.2B yen with cash reserves, Operating CF/Net Income ratio 4.03x demonstrating strong cash conversion well above earnings. [Investment Efficiency] Total asset turnover 0.890x, reflecting capital-intensive manufacturing operations, CapEx of 6.2B yen versus depreciation of 5.8B yen yields CapEx/Depreciation ratio of 1.07x indicating ongoing growth and maintenance investments. [Financial Health] Equity ratio 37.8% (improved from 37.2% YoY), current ratio 138.9% indicating adequate short-term liquidity, Debt-to-Equity ratio 0.99x, total interest-bearing debt 36.7B yen (short-term 16.2B yen, long-term 20.5B yen), Debt/EBITDA 3.49x, interest coverage 9.86x (Operating Income plus non-operating income divided by interest expense) demonstrating capacity to service debt obligations though financial leverage warrants monitoring.
Operating CF of 9.3B yen increased 8.4% YoY, representing 4.03x Net Income and confirming strong cash-backed earnings quality. Operating CF subtotal before working capital changes totaled 11.1B yen, with depreciation and amortization of 5.8B yen contributing non-cash addbacks. Working capital changes consumed 0.3B yen net, comprising minimal inventory change (-0.0B yen), modest improvement from receivables collection (+0.2B yen), offset by payables reduction (-0.4B yen) and contract liabilities decrease (-0.3B yen). Income taxes paid totaled 1.4B yen and interest paid 0.5B yen. Investing CF outflow of 6.3B yen was primarily CapEx of 6.2B yen, maintaining production capacity and pursuing growth investments. FCF of 3.0B yen (Operating CF minus Investing CF) demonstrates solid cash generation capacity after capital investments. Financing CF inflow of 1.1B yen reflected net borrowing activities, with long-term debt increasing 4.6B yen YoY to 20.5B yen, indicating refinancing of short-term obligations or funding for investments. Share repurchases were minimal at 0.0B yen. Overall cash position strengthened to 18.7B yen (+28.3% YoY), providing enhanced financial flexibility. The strong Operating CF/EBITDA ratio of 0.88x and accrual ratio of -7.1% both indicate high-quality earnings with minimal accruals, supporting sustainable cash generation.
Operating Income of 4.7B yen versus Ordinary Income of 4.2B yen indicates net non-operating expense of approximately 0.5B yen, primarily comprising interest expense of 0.5B yen, foreign exchange losses of 0.1B yen, partially offset by interest and dividend income of 0.1B yen. Non-operating expenses represented 0.6% of revenue, a manageable level for a manufacturing company with overseas operations. However, extraordinary losses totaling 0.5B yen (impairment loss 0.3B yen, asset disposal losses 0.0B yen, and other losses 0.2B yen) significantly impacted bottom-line results, representing 22.3% of Net Income before extraordinary items. These non-recurring factors reduced pre-tax income from 4.2B yen to 3.7B yen, highlighting earnings volatility from asset-related charges. Operating CF of 9.3B yen substantially exceeds Net Income of 0.1B yen, yielding Operating CF/Net Income ratio of 4.03x, which strongly indicates healthy underlying earnings quality despite one-time charges depressing reported net income. The negative accrual ratio of -7.1% further confirms cash-backed profitability. Interest burden coefficient of 0.774 (Profit before Tax / Operating Income) reveals that approximately 23% of operating profit is consumed by net non-operating expenses including interest, representing a material drag on profitability that warrants monitoring given the interest-bearing debt load of 36.7B yen.
Full-year guidance projects Revenue of 88.4B yen (+1.3% YoY), Operating Income of 4.9B yen (+4.2% YoY), Ordinary Income of 4.4B yen (+5.0% YoY), and Net Income of 2.9B yen. Current period achievement rates stand at Revenue 98.6%, Operating Income 96.7%, Ordinary Income 95.0%, which are significantly ahead of the standard 100% completion rate expected for full-year results, indicating the company is on track to meet or potentially exceed guidance. The stronger-than-expected current performance suggests conservative full-year assumptions or potential upside risk to forecasts. EPS forecast of 35.78 yen implies significant second-half improvement from current period EPS of 28.50 yen. The company maintains annual dividend forecast of 7.00 yen unchanged. Contract liabilities of 5.2B yen on the balance sheet represent advance customer payments, providing forward revenue visibility. The Backlog/Revenue ratio of approximately 6.0% (contract liabilities of 5.2B yen relative to annual revenue of 87.2B yen) indicates modest but stable forward order coverage of approximately 22 days of revenue. Forecast assumptions, per company disclosure, are based on currently available information and subject to various uncertainties. The second-half outlook appears to embed expectations for sustained mold segment momentum and stabilization in the molded products segment, with reduced extraordinary losses contributing to normalized net income progression.
Annual dividend of 7.00 yen per share is maintained flat versus prior year's 7.00 yen. Dividend payout ratio is 40.7% of forecast EPS of 35.78 yen, representing a moderate and sustainable level relative to normalized earnings. However, when calculated against current period Net Income attributable to owners of 0.1B yen (2.30B yen), the actual payout ratio would be significantly elevated, though this reflects the distortion from extraordinary losses rather than underlying earnings capacity. Total projected dividend payment of approximately 0.6B yen is well covered by Operating CF of 9.3B yen (FCF coverage of 4.75x) and FCF of 3.0B yen (FCF dividend coverage of 5.0x), confirming strong cash-backed dividend sustainability. Share buybacks during the period were minimal at 0.0B yen. Total return ratio (dividends only, as buybacks negligible) equals the payout ratio of approximately 40.7% based on forecast earnings. The company's shareholder return policy appears conservative and sustainable, prioritizing dividend stability supported by operating cash flow generation rather than aggressive payout or significant share repurchases. Cash reserves of 18.7B yen provide additional buffer for dividend continuity through business cycles.
Customer concentration risk: The largest customer PT Astemo Indonesia Automotive System accounted for 9.4B yen or 10.8% of total revenue, creating material dependency on a single account. Loss of or reduced orders from this customer would significantly impact financial performance, particularly as historical sales to this customer declined from 10.4B yen to 9.4B yen (-9.6% YoY).
Refinancing and liquidity risk: Short-term debt of 16.2B yen represents 44.2% of total liabilities, approaching concerning levels requiring active refinancing. While current ratio of 138.9% and cash coverage of 1.15x provide near-term cushion, the significant short-term debt maturity profile creates rollover risk if credit conditions tighten or operating performance deteriorates. Elevated Debt/EBITDA of 3.49x limits financial flexibility.
Interest rate and profitability pressure: Interest burden coefficient of 0.774 indicates approximately 23% of operating profit is consumed by net non-operating expenses including interest expense of 0.5B yen annually. Rising interest rates on the 36.7B yen debt portfolio would further compress net profitability. Combined with recurring extraordinary losses (0.3B yen impairment in current year, 0.01B yen prior year), the company faces structural pressure on bottom-line margins requiring operational improvement to offset financial costs.
[Industry Position] (Reference - Proprietary Analysis)
Within the precision molding and mold manufacturing industry, the company's operating margin of 5.4% reflects moderate but improving profitability positioning. Industry participants typically operate with operating margins ranging from 4-8% depending on product mix, scale, and geographic exposure. The company's equity ratio of 37.8% indicates conservative financial structure relative to industry norms where median leverage tends toward 40-50% equity ratios. ROE of 0.2% for the current period is significantly depressed by extraordinary items and represents temporary underperformance versus industry median ROE typically in the 5-10% range for established precision manufacturing firms. Asset turnover of 0.890x is consistent with capital-intensive precision manufacturing operations. The company's gross margin of 20.7% and relatively stable customer relationships reflect competitive positioning in specialized precision mold and molded products markets serving automotive and industrial end-markets. Industry dynamics include exposure to automotive production cycles, competition from lower-cost Asian manufacturers, and pressure for technological advancement in precision manufacturing capabilities. The company's geographic diversification across Japan, China, Thailand, and Indonesia provides partial mitigation of regional demand volatility common in the industry.
Operating leverage is driving margin expansion: Revenue growth of 5.7% translated into operating profit growth of 17.1%, with operating margin improving 0.5pt to 5.4% as gross margin expanded (+0.8pt) and SG&A ratio improved (-0.3pt). This demonstrates effective cost management and scalability, with the company positioned to further benefit from volume growth. The Injection Molding Precision Mold segment showing 107.6% profit growth on 18.5% revenue growth highlights particularly strong operational leverage in this higher-value segment, representing a strategic growth opportunity warranting continued focus.
Cash generation significantly exceeds reported earnings: Operating CF of 9.3B yen represents 4.03x Net Income and OCF/EBITDA of 0.88x, indicating high-quality, cash-backed profitability. Accrual ratio of -7.1% confirms minimal earnings manipulation risk. Free cash flow of 3.0B yen after sustaining CapEx of 6.2B yen provides substantial financial flexibility. This strong cash generation supports dividend sustainability (FCF coverage 4.75x), debt service capacity (interest coverage 9.86x), and potential for debt reduction or growth investments. The divergence between cash-based performance and reported net income (constrained by 0.5B yen extraordinary losses and 0.5B yen interest expense) suggests underlying business health is materially stronger than headline earnings indicate.
Balance sheet structure requires attention despite improving liquidity: Short-term debt representing 44.2% of total liabilities creates refinancing risk concentration, though cash buildup to 18.7B yen (+28.3% YoY) and current ratio improvement to 138.9% provide near-term mitigation. Debt/EBITDA of 3.49x is elevated for a cyclical manufacturing business, limiting financial flexibility and contributing to high interest burden (23% of operating profit consumed by net non-operating expenses). The 4.6B yen increase in long-term debt suggests management is actively addressing debt maturity profile, but progress in deleveraging through EBITDA growth or absolute debt reduction would enhance financial stability and reduce earnings volatility from interest rate exposure. Contract liabilities of 5.2B yen provide modest forward revenue visibility of approximately 22 days, indicating stable but not exceptional order backlog relative to annual revenue run rate.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.